特朗普政府敲定新规，要求药品福利管理机构向雇主披露全部报酬
STAT+: New federal rule will require prescription drug middlemen to share secret payments data
特朗普政府周四敲定一项法规，要求药品福利管理机构（PBM）向雇主披露其从药企、咨询公司等各方获得的所有费用与报酬，包括药品返点、价差定价以及与经纪商和顾问之间可能产生利益冲突的财务关系，披露自 2027 年 7 月 1 日起执行。联邦官员估计该规则将覆盖 70 多家 PBM 和 13 万家雇主，每年可通过降低药价节省超过 8 亿美元。PBM 与游说机构此前曾警告可能就特朗普的这一提案采取法律行动。
PBMs, lobbyists previously warned they may take legal action over Trump’s proposal
By Bob Herman
Oct. 29, 2026
Bob Herman is the author of Health Care Inc., an award-winning weekly newsletter about the business of health and medicine.
Bob covers the money in health care, focusing on health insurance and hospitals. His stories delve into Medicare Advantage, opaque prescription drug benefits, and how much executives actually make. He is also the author of the Health Care Inc. newsletter. You can reach Bob on Signal at bobjherman.09.
The middlemen that oversee prescription drug spending for employers and workers will soon have to tell their clients all the different ways they get paid, a significant move that will unlock reams of highly protected data.
The Trump administration finalized a regulation Thursday that will force pharmacy benefit managers to disclose all the different fees and compensation they get from drugmakers, consulting firms, and other entities to the employers that hire them. The disclosures — which will be required starting on July 1, 2027 — will include drug rebates, spread pricing, and financial relationships with brokers and consultants that could create conflicts of interest.
Federal officials estimate the rule will apply to more than 70 PBMs and 130,000 employers, saving more than $800 million annually through lower drug costs.
STAT+ Exclusive Story
Already have an account? Log in
This article is exclusive to STAT+ subscribers
Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts.
Already have an account? Log in
To read the rest of this story subscribe to STAT+.
-
Business of Health Care Reporter
Bob covers the money in health care, focusing on health insurance and hospitals. His stories delve into Medicare Advantage, opaque prescription drug benefits, and how much executives actually make. He is also the author of the Health Care Inc. newsletter. You can reach Bob on Signal at bobjherman.09.
来源：STAT News · statnews.com